0RG8.IL

Sartorius Stedim Biotech S.A.

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$21.23B

PE Ratio

97.39

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$3.43B

Net Income (TTM)

$218.0M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

8.00%

Profit Margin

9.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core5 fields›

Market Cap$21.23B

Revenue TTM$3.43B

Shares Outstanding0.00M

Insider Ownership71.00%

Institutional Ownership12.00%

Growth Estimates4 fields›

Revenue Growth (Quarterly YoY)8.00%

Rev Growth Est 1Y Forward0.09

EPS Growth (Quarterly YoY)154.00%

EPS Growth Est Quarterly0

Operations12 fields›

Revenue TTM$3.43B

Gross Margin TTM46.00%

Operating Margin TTM19.00%

Operating Expenses TTM$0.00M

Profit Margin TTM9.00%

Net Income TTM$218.0M

EBIT Margin TTM33.81%

EBITDA Margin TTM26.00%

EBITDA TTM$885.7M

CFO TTM$627.5M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

Efficiency1 fields›

ROA4.00%

Valuation5 fields›

P/E (TTM)97.39

P/E Forward0

EV/Revenues (TTM)0

Earnings Yield1.00%

Payout Ratio34.00%

Liquidity2 fields›

Current Ratio1.61

Interest Expense$0.00M

Yields2 fields›

Payout Ratio34.00%

Earnings Yield1.00%